fbpx

First Page

Growing & Analyzing Cells at their Best

BioSpherix and Phase Holographic Imaging (PHI) have teamed up to support researchers in their ambition to grow and analyze cells in a cell-friendly environment, without cell disturbing factors like labels, stains and temperature fluctuations.
Read More

Advancing methods for the analysis of glioblastoma cell motion using quantitative time-lapse holographic imaging and cellular tomography

The Label-free cell analysis technology, using HoloMonitor cell-based assays, is an easy way to capture cell events and more information from individual cells.
Read More

New SelectScience eBook helps scientists choose the best cell imaging technology

A new cell imaging technology guide has been launched by leading independent science publisher SelectScience® to help scientists find the best equipment for their applications.
Read More

Interim Report 1 2019/20

Interim Report 1 2019/20 -
Read More

Årsredovisning 2018/19

Styrelsen och verkställande direktören för Phase Holographic Imaging PHI AB (publ), organisationsnummer 556542-7811 och med säte i Lund, avger härmed årsredovisning för räkenskapsåret 1 maj 2018 – 30 april 2019.  
Read More

Kallelse till årsstämma i Phase Holographic Imaging PHI AB (publ)

Aktieägarna i Phase Holographic Imaging PHI AB (publ), 556542-7811, kallas härmed till årsstämma tisdagen den 15 oktober 2019 kl. 17.00 i bolagets lokaler, Scheelevägen 22 i Lund. Rätt att delta och anmälan Aktieägare som önskar delta i bolagsstämman ska • vara införd i den av Euroclear Sweden AB förda aktieboken onsdagen den 9 oktober 2019, …
Read More

US National Institutes of Health intends to purchase HoloMonitor

The US National Institute of Aging intends to purchase a HoloMonitor instrument from Phase Holographic Imaging. The National Institute of Aging is part of the National Institutes of Health (NIH), a government agency to promote medical research.
Read More

PHI and leading supplier of cell analysis instrumentation sign agreement

Phase Holographic Imaging (PHI) and a major publicly traded international supplier of laboratory equipment and cell analysis instrumentation have entered an agreement aiming to determine the scope and nature of a future partnership. The agreement is a result of discussions between the company management teams, over an extended period time.
Read More

PHI establish US subsidiary to foster US partnerships

As part of the ongoing expansion of activities on the US market, the Board of Directors of Phase Holographic Imaging (PHI) has initiated the process of establishing a fully owned subsidiary in the US.
Read More

PHI releases App Suite 2 – more apps and greater applicability

App Suite 2 is the second release in a series of planned App Suite releases, developed to provide automated live-cell studies to researchers worldwide in an unprecedented user-friendly workflow, using PHI’s HoloMonitor-technology.
Read More